Form 13-F position report

ORAMED PHARM INC

Reported by SG Americas Securities LLC

ORMP CUSIP 68403P203 Manager CIK 0001313360

Reported 10,370 shares, down 36,162 (77.7%) from the prior quarter.

Reported value -68.5%; share count -77.7% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q3 2022
Shares 10,370 Quarter-end amount reported
Reported value $67,000 Fair value at quarter end
Consecutive quarters held 5 Through Q3 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 298000
2021-12-31 123000
2022-03-31 0
2022-06-30 213000
2022-09-30 67000
2022-12-31 125000
2023-03-31 0
2025-03-31 50000
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for ORAMED PHARM INC held by SG Americas Securities LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -23,446 (-100.0%) 0 $0 2025-08-08
Q1 2025 New 23,446 +23,446 (0.0%) < 0.01% $50,000 2025-04-15
Q1 2023 Reduced 0 -10,370 (-100.0%) 0 $0 2023-04-28
Q4 2022 Unchanged 10,370 0 (0.0%) < 0.01% $125,000 2023-02-02
Q3 2022 Reduced 10,370 -36,162 (-77.7%) < 0.01% $67,000 2022-10-31
Q2 2022 New 46,532 +46,532 (0.0%) < 0.01% $213,000 2022-07-29
Q1 2022 Reduced 0 -8,631 (-100.0%) 0 $0 2022-04-29
Q4 2021 Reduced 8,631 -4,910 (-36.3%) < 0.01% $123,000 2022-02-07
Q3 2021 New 13,541 +13,541 (0.0%) < 0.01% $298,000 2021-11-01

Who else reported the position

82 managers reported ORAMED PHARM INC for Q3 2022.

Managers reporting ORAMED PHARM INC in Q3 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
MORGAN STANLEY Reduced 527,106 -159,485 < 0.01% $3,416,000 36 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 503,031 -77,352 < 0.01% $3,260,000 13 qtrs
TWO SIGMA ADVISERS LP Reduced 331,500 -350,300 < 0.01% $2,148,000 4 qtrs
JPMorgan Chase & Co Reduced 284,603 -51,946 < 0.01% $1,844,000 6 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Added 171,337 +64,699 < 0.01% $1,110,000 7 qtrs
TWO SIGMA INVESTMENTS LP Reduced 163,015 -476,542 < 0.01% $1,056,000 4 qtrs
Cubist Systematic Strategies LLC Added 117,477 +46,756 < 0.01% $761,000 4 qtrs
CITADEL ADVISORS LLC Reduced 106,866 -541,967 < 0.01% $692,000 9 qtrs
BlackRock Inc Reduced 102,199 -36,853 < 0.01% $662,000 18 qtrs
ETF MANAGERS GROUP LLC Added 94,493 +7,128 0.02% $612,000 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2022
Filed
October 31, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
10,370
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.